
|Articles|October 15, 2018
Personalized Treatments Hold Promise for Lymphoma Patients
Author(s)Stephanie Stephens, MA
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Advertisement
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
2
Biosimilars in 2025: A year of firsts
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5






















































